Index - P/E - EPS (ttm) -0.74 Insider Own 2.14% Shs Outstand 30.30M Perf Week -1.09%
Market Cap 6.95B Forward P/E 431.25 EPS next Y 0.53 Insider Trans -11.64% Shs Float 29.65M Perf Month 16.03%
Income -21.15M PEG - EPS next Q -0.65 Inst Own 102.54% Short Float 7.01% Perf Quarter 14.06%
Sales 624.80M P/S 11.12 EPS this Y 55.06% Inst Trans 2.55% Short Ratio 4.09 Perf Half Y 45.95%
Book/sh 19.37 P/B 11.84 EPS next Y 264.29% ROA -3.41% Short Interest 2.08M Perf Year -13.04%
Cash/sh 15.19 P/C 15.09 EPS next 5Y 54.10% ROE -3.96% 52W Range 123.27 - 330.00 Perf YTD 12.68%
Dividend Est. - P/FCF 6809.18 EPS past 5Y 13.57% ROI -3.54% 52W High -30.54% Beta 1.34
Dividend TTM - Quick Ratio 7.17 Sales past 5Y 66.60% Gross Margin 84.54% 52W Low 85.95% ATR (14) 11.85
Dividend Ex-Date - Current Ratio 7.60 EPS Y/Y TTM 54.94% Oper. Margin -6.45% RSI (14) 56.53 Volatility 6.15% 5.15%
Employees 1011 Debt/Eq 0.04 Sales Y/Y TTM 53.19% Profit Margin -3.39% Recom 1.70 Target Price 255.32
Option/Short Yes / Yes LT Debt/Eq 0.04 EPS Q/Q 368.07% Payout - Rel Volume 1.09 Prev Close 241.15
Sales Surprise 3.08% EPS Surprise 1015.89% Sales Q/Q 39.60% Earnings May 07 AMC Avg Volume 508.66K Price 229.22
SMA20 4.23% SMA50 13.03% SMA200 12.10% Trades
Volume 556,123 Change -4.95%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-19-24 Initiated RBC Capital Mkts
Outperform
$285
Mar-19-24 Initiated Morgan Stanley
Overweight
$250
Feb-06-24 Resumed KeyBanc Capital Markets
Overweight
$278
Jan-19-24 Initiated Jefferies
Buy
$245
Jan-02-24 Downgrade Stifel
Buy → Hold
$210
Dec-13-23 Downgrade Wells Fargo
Overweight → Equal Weight
$245 → $187
Jul-19-23 Initiated Robert W. Baird
Outperform
$371
Apr-14-23 Initiated Mizuho
Buy
$300
Mar-29-23 Initiated UBS
Buy
$300
Dec-13-22 Upgrade Goldman
Neutral → Buy
$245 → $308
Dec-13-22 Initiated KeyBanc Capital Markets
Overweight
$287
Apr-13-22 Initiated Truist
Buy
$315
Apr-06-22 Initiated Wolfe Research
Peer Perform
$270
Mar-02-22 Resumed BofA Securities
Buy
$270
Jan-04-21 Downgrade BofA Securities
Buy → Neutral
Dec-15-20 Downgrade Goldman
Buy → Neutral
$162 → $209
Nov-03-20 Upgrade Oppenheimer
Underperform → Perform
Nov-03-20 Upgrade BofA Securities
Neutral → Buy
$125 → $155
Sep-22-20 Initiated JP Morgan
Overweight
$148
Sep-02-20 Initiated Robert W. Baird
Outperform
$130
Show Previous Ratings
Apr-18-24 12:17PM
02:14AM
Apr-17-24 08:38AM
(The Wall Street Journal) +9.87%
Apr-08-24 05:17AM
Apr-02-24 08:00AM
07:00PM
Loading…
Mar-27-24 07:00PM
Mar-21-24 02:31AM
Mar-18-24 12:01PM
Mar-14-24 01:49AM
Mar-05-24 08:00AM
Feb-13-24 09:02AM
05:45AM
Feb-07-24 11:33AM
(Thomson Reuters StreetEvents) -10.55%
11:15AM
10:02AM
06:30PM
Loading…
Feb-06-24 06:30PM
05:35PM
04:35PM
04:02PM
Feb-05-24 08:00AM
Feb-04-24 06:56AM
Feb-01-24 06:55AM
Jan-30-24 10:00AM
Jan-26-24 08:00AM
Jan-24-24 10:15AM
Jan-19-24 01:12AM
Jan-10-24 10:45AM
Jan-09-24 10:39AM
08:00AM
Jan-08-24 08:00AM
01:07PM
Loading…
Jan-05-24 01:07PM
Dec-29-23 09:00AM
Dec-28-23 08:00AM
Dec-27-23 06:26PM
05:05AM
Dec-21-23 10:30PM
Dec-18-23 08:00AM
Dec-07-23 11:30AM
06:08AM
Nov-30-23 11:20AM
Nov-14-23 03:58PM
08:00AM
Nov-11-23 01:34PM
Nov-09-23 12:41PM
Nov-08-23 05:52PM
07:30AM
Nov-07-23 04:03PM
Nov-01-23 08:00AM
Oct-31-23 10:01AM
Oct-30-23 04:05PM
Oct-23-23 08:00AM
Oct-19-23 08:55AM
Oct-17-23 02:01PM
Oct-11-23 11:40AM
Oct-03-23 08:00AM
Sep-26-23 11:19AM
08:00AM
Sep-22-23 09:05AM
Sep-21-23 09:25AM
09:25AM
07:00AM
(Investor's Business Daily)
01:00AM
Sep-20-23 12:39PM
Sep-06-23 02:52AM
Aug-23-23 08:00AM
Aug-10-23 09:22AM
Aug-02-23 11:25AM
Aug-01-23 07:00PM
05:25PM
04:02PM
Jul-31-23 09:43AM
08:00AM
Jul-25-23 11:53AM
05:40AM
Jul-24-23 08:00AM
Jul-05-23 08:00AM
Jun-26-23 10:50AM
Jun-21-23 08:41PM
Jun-15-23 02:39PM
(Investor's Business Daily)
Jun-14-23 03:00AM
Jun-12-23 09:23AM
Jun-09-23 09:15AM
08:00AM
Jun-05-23 08:00AM
Jun-01-23 11:31AM
09:40AM
May-22-23 11:10AM
May-18-23 07:35AM
May-16-23 08:00AM
May-05-23 08:26AM
May-04-23 10:05AM
May-03-23 11:03AM
(Thomson Reuters StreetEvents) +6.96%
08:41AM
08:00AM
08:00AM
May-02-23 05:15PM
04:02PM
Apr-28-23 11:38AM
(Investor's Business Daily)
Apr-26-23 08:00AM
Apr-25-23 11:43AM
Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Buchholz Richard Chief Financial Officer Apr 17 '24 Sale 230.03 15,000 3,450,450 28,271 Apr 18 04:44 PM NELSON MARILYN C Director Apr 01 '24 Option Exercise 16.00 3,273 52,368 34,338 Apr 02 08:29 PM Griffin Jerry C Director Apr 01 '24 Option Exercise 16.00 296 4,736 10,932 Apr 03 04:55 PM Herbert Timothy P. CEO and President Apr 01 '24 Sale 205.09 40,000 8,203,581 63,658 Apr 03 07:44 PM Griffin Jerry C Director Apr 01 '24 Sale 213.99 32 6,848 10,900 Apr 03 04:55 PM NELSON MARILYN C Director Mar 27 '24 Option Exercise 90.85 3,243 294,633 31,065 Mar 29 04:49 PM Griffin Jerry C Director Mar 25 '24 Option Exercise 16.00 1,000 16,000 11,190 Mar 27 04:01 PM Griffin Jerry C Director Mar 25 '24 Sale 197.81 554 109,587 10,636 Mar 27 04:01 PM Rondoni John Chief Technology Officer Mar 22 '24 Sale 194.40 4,387 852,849 11,270 Mar 26 08:23 PM Griffin Jerry C Director Mar 18 '24 Option Exercise 16.00 1,000 16,000 10,744 Mar 20 05:51 PM Griffin Jerry C Director Mar 18 '24 Sale 193.53 554 107,216 10,190 Mar 20 05:51 PM Griffin Jerry C Director Mar 11 '24 Option Exercise 16.00 1,000 16,000 10,298 Mar 13 09:21 PM Griffin Jerry C Director Mar 11 '24 Sale 198.05 554 109,720 9,744 Mar 13 09:21 PM Griffin Jerry C Director Mar 01 '24 Option Exercise 16.00 1,000 16,000 9,852 Mar 05 05:08 PM NELSON MARILYN C Director Mar 01 '24 Option Exercise 0.94 2,555 2,402 27,822 Mar 05 05:06 PM Griffin Jerry C Director Mar 01 '24 Sale 179.44 554 99,410 8,298 Mar 05 05:08 PM Rondoni John Chief Technology Officer Feb 29 '24 Sale 179.25 8,605 1,542,441 15,657 Mar 04 06:21 PM Ban Randy Chief Commercial Officer Feb 27 '24 Option Exercise 42.15 3,060 128,979 6,089 Feb 27 08:39 PM Ban Randy Chief Commercial Officer Feb 27 '24 Sale 182.01 3,060 556,951 3,029 Feb 27 08:39 PM Ban Randy Chief Commercial Officer Feb 23 '24 Option Exercise 4.11 12,230 50,234 15,259 Feb 27 08:39 PM Ban Randy Chief Commercial Officer Feb 23 '24 Sale 185.37 12,230 2,267,075 3,029 Feb 27 08:39 PM Rondoni John Chief Technology Officer Feb 15 '24 Option Exercise 2.07 8,000 16,560 24,262 Feb 16 04:05 PM NELSON MARILYN C Director Feb 09 '24 Option Exercise 0.94 4,000 3,760 25,267 Feb 13 04:01 PM Jandrich Steven VP, Human Resources Jan 30 '24 Option Exercise 0.94 16,225 15,252 23,096 Jan 31 08:40 PM NELSON MARILYN C Director Oct 17 '23 Option Exercise 0.94 2,000 1,880 21,100 Oct 17 07:52 PM Herbert Timothy P. CEO and President Oct 12 '23 Option Exercise 5.43 208,036 1,128,811 203,691 Oct 16 07:53 PM Sparks Charisse Y Chief Medical Officer Oct 12 '23 Buy 153.50 100 15,350 998 Jan 24 04:32 PM NELSON MARILYN C Director Sep 21 '23 Option Exercise 0.94 2,000 1,880 18,959 Sep 25 06:30 PM NELSON MARILYN C Director Sep 14 '23 Option Exercise 0.94 2,000 1,880 16,959 Sep 18 04:35 PM Jandrich Steven VP, Human Resources Aug 28 '23 Option Exercise 0.94 2,500 2,350 6,871 Aug 30 07:40 PM Herbert Timothy P. CEO and President Aug 23 '23 Option Exercise 70.55 953 67,230 107,784 Aug 28 08:03 AM NELSON MARILYN C Director Aug 21 '23 Option Exercise 0.94 2,000 1,880 14,959 Aug 22 04:05 PM NELSON MARILYN C Director Aug 10 '23 Option Exercise 0.94 2,000 1,880 12,959 Aug 11 04:01 PM NELSON MARILYN C Director Aug 07 '23 Option Exercise 0.94 2,000 1,880 10,959 Aug 09 04:05 PM NELSON MARILYN C Director Aug 04 '23 Option Exercise 0.94 2,000 1,880 8,959 Aug 08 05:00 PM Griffin Jerry C Director Jul 31 '23 Option Exercise 16.00 1,000 16,000 9,381 Aug 01 06:26 PM Griffin Jerry C Director Jul 31 '23 Sale 290.47 529 153,659 8,852 Aug 01 06:26 PM Griffin Jerry C Director Jul 24 '23 Option Exercise 16.00 1,000 16,000 8,910 Jul 26 04:15 PM NELSON MARILYN C Director Jul 24 '23 Option Exercise 0.94 2,000 1,880 6,959 Jul 27 06:29 PM Griffin Jerry C Director Jul 24 '23 Sale 304.99 529 161,340 8,381 Jul 26 04:15 PM Griffin Jerry C Director Jul 17 '23 Option Exercise 16.00 1,000 16,000 8,439 Jul 19 04:50 PM Griffin Jerry C Director Jul 17 '23 Sale 326.84 529 172,898 7,910 Jul 19 04:50 PM Griffin Jerry C Director Jul 10 '23 Option Exercise 16.00 1,000 16,000 7,968 Jul 12 06:00 PM Griffin Jerry C Director Jul 10 '23 Sale 310.42 529 164,212 7,439 Jul 12 06:00 PM Griffin Jerry C Director Jul 03 '23 Option Exercise 16.00 1,000 16,000 7,497 Jul 06 05:26 PM Griffin Jerry C Director Jul 03 '23 Sale 322.09 529 170,386 6,968 Jul 06 05:26 PM Griffin Jerry C Director Jun 26 '23 Option Exercise 16.00 1,000 16,000 7,026 Jun 28 06:21 PM Griffin Jerry C Director Jun 26 '23 Sale 315.87 529 167,095 6,497 Jun 28 06:21 PM Griffin Jerry C Director Jun 20 '23 Option Exercise 16.00 1,000 16,000 6,555 Jun 22 04:07 PM Griffin Jerry C Director Jun 20 '23 Sale 307.64 529 162,742 6,026 Jun 22 04:07 PM Griffin Jerry C Director Jun 12 '23 Option Exercise 16.00 1,000 16,000 6,084 Jun 14 05:56 PM Griffin Jerry C Director Jun 12 '23 Sale 309.03 529 163,477 5,555 Jun 14 05:56 PM Griffin Jerry C Director Jun 05 '23 Option Exercise 16.00 1,000 16,000 5,613 Jun 07 05:57 PM Griffin Jerry C Director Jun 05 '23 Sale 305.69 529 161,710 5,084 Jun 07 05:57 PM Griffin Jerry C Director May 30 '23 Option Exercise 16.00 1,000 16,000 5,142 Jun 01 05:59 PM Griffin Jerry C Director May 30 '23 Sale 294.90 529 156,002 4,613 Jun 01 05:59 PM Griffin Jerry C Director May 22 '23 Option Exercise 16.00 1,000 16,000 4,671 May 24 04:04 PM Griffin Jerry C Director May 22 '23 Sale 307.52 529 162,678 4,142 May 24 04:04 PM Griffin Jerry C Director May 15 '23 Option Exercise 16.00 1,000 16,000 4,200 May 17 08:23 PM Griffin Jerry C Director May 15 '23 Sale 293.91 529 155,478 3,671 May 17 08:23 PM Jandrich Steven VP, Human Resources May 12 '23 Option Exercise 71.00 4,525 321,275 8,896 May 16 05:32 PM Jandrich Steven VP, Human Resources May 12 '23 Sale 292.84 4,525 1,325,107 4,371 May 16 05:32 PM Jandrich Steven VP, Human Resources May 08 '23 Option Exercise 42.15 1,727 72,793 6,098 May 10 08:17 PM Griffin Jerry C Director May 08 '23 Option Exercise 16.00 1,000 16,000 3,729 May 10 08:16 PM Jandrich Steven VP, Human Resources May 08 '23 Sale 280.12 1,727 483,767 4,371 May 10 08:17 PM Griffin Jerry C Director May 08 '23 Sale 280.00 529 148,120 3,200 May 10 08:16 PM Jandrich Steven VP, Human Resources Apr 25 '23 Option Exercise 42.15 8,000 337,200 12,371 May 03 04:35 PM Jandrich Steven VP, Human Resources Apr 25 '23 Sale 271.02 8,000 2,168,164 4,371 May 03 04:35 PM
Index RUT P/E - EPS (ttm) -1.60 Insider Own 9.31% Shs Outstand 38.52M Perf Week -4.82%
Market Cap 289.44M Forward P/E - EPS next Y -1.58 Insider Trans -2.10% Shs Float 34.95M Perf Month -21.20%
Income -60.84M PEG - EPS next Q -0.47 Inst Own 87.89% Short Float 3.22% Perf Quarter -42.28%
Sales 68.67M P/S 4.21 EPS this Y -15.97% Inst Trans -2.51% Short Ratio 1.97 Perf Half Y -11.23%
Book/sh 3.07 P/B 2.44 EPS next Y 15.10% ROA -32.62% Short Interest 1.13M Perf Year -39.19%
Cash/sh 3.04 P/C 2.47 EPS next 5Y 23.60% ROE -44.68% 52W Range 7.21 - 14.84 Perf YTD -41.10%
Dividend Est. - P/FCF - EPS past 5Y -25.16% ROI -39.38% 52W High -49.38% Beta 0.68
Dividend TTM - Quick Ratio 5.77 Sales past 5Y 30.02% Gross Margin 73.76% 52W Low 4.16% ATR (14) 0.42
Dividend Ex-Date - Current Ratio 6.49 EPS Y/Y TTM -0.89% Oper. Margin -90.18% RSI (14) 31.16 Volatility 4.75% 4.75%
Employees 279 Debt/Eq 0.35 Sales Y/Y TTM 27.98% Profit Margin -88.60% Recom 1.33 Target Price 16.83
Option/Short Yes / Yes LT Debt/Eq 0.31 EPS Q/Q 5.29% Payout - Rel Volume 0.61 Prev Close 7.50
Sales Surprise 5.66% EPS Surprise 11.94% Sales Q/Q 24.98% Earnings May 01 AMC Avg Volume 570.65K Price 7.51
SMA20 -10.60% SMA50 -24.95% SMA200 -31.77% Trades
Volume 347,792 Change 0.13%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-23-24 Downgrade Wells Fargo
Overweight → Equal Weight
$16 → $14
Sep-05-23 Initiated Craig Hallum
Buy
$18
Feb-27-23 Upgrade Wells Fargo
Equal Weight → Overweight
$10 → $15
Jan-03-23 Downgrade BofA Securities
Neutral → Underperform
$8
Dec-12-22 Upgrade Citigroup
Neutral → Buy
$14 → $10
Jul-11-22 Downgrade Citigroup
Buy → Neutral
$23 → $19
Mar-02-22 Resumed BofA Securities
Neutral
$28
Dec-08-21 Upgrade Piper Sandler
Neutral → Overweight
$45
Apr-01-21 Initiated Citigroup
Buy
$60
Mar-25-21 Initiated Piper Sandler
Neutral
$50
Mar-10-21 Upgrade BofA Securities
Neutral → Buy
$72
Jan-04-21 Downgrade BofA Securities
Buy → Neutral
Oct-26-20 Initiated Wells Fargo
Equal Weight
$46
Oct-26-20 Initiated Stifel
Buy
$50
Oct-26-20 Initiated Morgan Stanley
Equal-Weight
$44
Oct-26-20 Initiated Canaccord Genuity
Buy
$49
Oct-26-20 Initiated BofA Securities
Buy
$50
Show Previous Ratings
Apr-10-24 04:05PM
Apr-02-24 04:05PM
Mar-15-24 05:00PM
Feb-29-24 11:35PM
Feb-26-24 08:00AM
09:55AM
Loading…
Feb-22-24 09:55AM
06:56AM
(Thomson Reuters StreetEvents)
Feb-21-24 04:44PM
04:06PM
04:05PM
Feb-17-24 12:08AM
Feb-13-24 01:08PM
Feb-07-24 04:05PM
Dec-22-23 11:19PM
Dec-11-23 09:00AM
01:08PM
Loading…
Nov-17-23 01:08PM
Nov-15-23 04:05PM
Oct-31-23 04:05PM
09:00AM
07:03AM
(Thomson Reuters StreetEvents)
Oct-30-23 06:30PM
05:53PM
04:05PM
Oct-16-23 04:05PM
Oct-10-23 04:05PM
Aug-30-23 04:05PM
Aug-02-23 05:55PM
04:05PM
Jul-26-23 04:05PM
Jul-19-23 04:05PM
08:00AM
Loading…
Jul-17-23 08:00AM
Jul-10-23 08:47AM
May-03-23 10:43AM
(Thomson Reuters StreetEvents) +8.63%
May-02-23 05:35PM
04:05PM
Apr-27-23 08:24PM
Apr-25-23 04:05PM
Apr-18-23 04:05PM
Apr-17-23 02:20PM
Feb-24-23 04:00PM
Feb-22-23 05:55PM
04:05PM
Feb-16-23 04:05PM
Feb-08-23 04:05PM
Jan-31-23 06:57AM
Dec-14-22 04:05PM
Nov-30-22 07:00AM
Nov-16-22 04:05PM
Nov-11-22 05:12AM
(Simply Wall St.) +14.36%
Nov-09-22 06:27AM
Nov-04-22 12:34PM
08:00AM
Nov-03-22 06:45PM
04:05PM
Oct-27-22 10:02AM
Oct-20-22 04:05PM
Oct-14-22 10:01AM
Oct-13-22 09:35AM
Sep-09-22 03:29PM
Aug-24-22 04:05PM
Aug-03-22 09:55AM
Aug-02-22 11:00PM
05:35PM
04:05PM
Jul-27-22 04:05PM
Jul-19-22 04:05PM
Jul-18-22 09:55AM
05:15AM
Jul-06-22 08:10AM
Jun-26-22 08:36AM
May-03-22 10:00PM
05:35PM
04:05PM
Apr-26-22 04:05PM
Apr-19-22 04:05PM
Feb-23-22 11:00PM
06:35PM
04:05PM
Feb-10-22 04:05PM
Feb-09-22 04:05PM
Jan-27-22 05:38PM
Jan-17-22 06:36AM
Jan-12-22 02:58PM
Jan-04-22 10:00AM
Dec-29-21 04:05PM
Dec-24-21 12:38AM
Dec-18-21 09:15AM
12:38AM
Dec-08-21 07:21AM
Nov-17-21 11:58AM
Nov-16-21 04:05PM
Nov-03-21 08:00AM
04:01AM
Nov-02-21 06:45PM
04:05PM
07:52AM
Oct-27-21 12:35PM
Oct-26-21 04:05PM
Oct-20-21 09:08AM
Sep-21-21 04:05PM
Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, Africa, Asia Pacific, and Other International segments. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER Mar 22 '24 Sale 9.36 1,184 11,082 307,868 Mar 26 05:53 PM French Glendon E. III PRESIDENT AND CEO Mar 01 '24 Sale 9.06 6,954 63,003 1,116,758 Mar 05 06:15 PM Lehman David Aaron GENERAL COUNSEL Mar 01 '24 Sale 9.06 4,351 39,420 145,488 Mar 05 06:18 PM Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER Mar 01 '24 Sale 9.06 3,097 28,059 239,952 Mar 05 06:22 PM McKune John INTERIM CFO Mar 01 '24 Sale 9.06 1,078 9,767 47,410 Mar 05 06:20 PM Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER Feb 22 '24 Sale 14.20 1,184 16,813 243,049 Feb 26 06:23 PM French Glendon E. III PRESIDENT AND CEO Feb 15 '24 Sale 14.60 20,000 292,000 1,121,344 Feb 16 07:11 PM Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER Jan 22 '24 Sale 13.13 1,184 15,546 244,233 Jan 24 05:41 PM French Glendon E. III PRESIDENT AND CEO Jan 18 '24 Sale 12.77 10,000 127,700 1,141,344 Jan 22 06:05 PM Rose Geoffrey Beran Chief Commercial Officer Dec 22 '23 Sale 12.75 1,184 15,096 245,417 Dec 27 04:19 PM French Glendon E. III President and CEO Dec 21 '23 Sale 12.42 10,000 124,200 1,151,344 Dec 22 06:12 PM French Glendon E. III President and CEO Dec 01 '23 Sale 10.34 6,676 69,030 1,161,344 Dec 05 05:41 PM Lehman David Aaron General Counsel Dec 01 '23 Sale 10.34 3,809 39,381 149,839 Dec 05 05:42 PM Rose Geoffrey Beran Chief Commercial Officer Dec 01 '23 Sale 10.34 2,868 29,655 246,601 Dec 05 05:46 PM McKune John Interim CFO Dec 01 '23 Sale 10.34 942 9,739 40,414 Dec 05 05:44 PM Rose Geoffrey Beran Chief Commercial Officer Nov 22 '23 Sale 10.60 1,184 12,550 249,469 Nov 27 06:14 PM Rose Geoffrey Beran Chief Commercial Officer Oct 23 '23 Sale 8.35 1,184 9,886 250,653 Oct 25 06:20 PM Rose Geoffrey Beran Chief Commercial Officer Sep 22 '23 Sale 10.51 1,184 12,444 251,837 Sep 26 06:15 PM French Glendon E. III President and CEO Sep 01 '23 Sale 10.01 6,527 65,335 1,168,020 Sep 06 05:50 PM Sung Derrick Chief Financial Officer Sep 01 '23 Sale 10.00 4,219 42,201 391,041 Sep 06 06:07 PM Lehman David Aaron General Counsel Sep 01 '23 Sale 10.01 3,772 37,758 153,648 Sep 06 05:52 PM Rose Geoffrey Beran Chief Commercial Officer Sep 01 '23 Sale 10.01 2,843 28,458 253,021 Sep 06 06:03 PM Rose Geoffrey Beran Chief Commercial Officer Aug 23 '23 Sale 10.54 1,184 12,479 255,864 Aug 25 05:40 PM French Glendon E. III President and CEO Jul 20 '23 Sale 12.68 15,000 190,200 1,174,547 Jul 24 06:30 PM French Glendon E. III President and CEO Jun 15 '23 Sale 12.68 10,000 126,800 1,189,547 Jun 20 06:08 PM French Glendon E. III President and CEO Jun 01 '23 Sale 11.48 6,533 75,009 1,199,547 Jun 02 06:38 PM Sung Derrick Chief Financial Officer Jun 01 '23 Sale 11.49 4,222 48,507 395,260 Jun 02 06:51 PM Lehman David Aaron General Counsel Jun 01 '23 Sale 11.48 3,776 43,348 157,420 Jun 02 06:40 PM Rose Geoffrey Beran Chief Commercial Officer Jun 01 '23 Sale 11.48 2,845 32,661 257,048 Jun 02 06:47 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
